| 摘要 |
A system and method for determining individualized medical intervention for a particular disease state, and especially for cancers, that includes the molecular profiling of a biological sample from the patient, 5 determining whether any molecular findings including one or more molecular mechanisms, and/or combinations of such exhibit a change in expression compared to a reference, and identifying a non-specific disease therapy or agent capable of interacting with the genes, gene expressed proteins, molecular mechanisms, or combinations of such molecular findings that 10 exhibited a change in expression. coo Scn Sco Ia < U C-,j cc SUBSTITUTE SHEET (RULE 26) |
